This webinar on November 21st examined how biomarkers are used to define “PD-L1” positive patients around the globe and in resource limited settings. It provided a forum for physicians to discuss their experience assessing different criteria, as well as the solutions that were implemented to...
This webinar on October 16th examined the importance of monitoring response to cancer immunotherapy, with a specific focus on image evaluation and predictive AI. The program featured discussions from leading scientists and radiologists in the field of IO on how feasible these tools are in a...
Thousands of IO clinical trials are currently available to cancer patients, all of which are aiming to identify the next generation of potential life-saving treatments. However, it can be difficult to design trials that will be able to efficiently enroll patients, especially in the field of...
Increased understanding of immunotherapy mechanisms of action may enhance researchers’ ability to circumvent resistance and identify alternative therapeutic uses. Imaging-based AI that can closely analyze drug-specific structures and interactions are being developed to help expedite discoveries...
SITC has provided comment on the recently posted "Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies; Guidance for Industry - Draft Guidance". SITC was pleased to see FDA incorporate feedback and topics that have stemmed from recent...
Earlier cancer diagnosis, as well as rapid determination of tumor response after treatment, could lead to enhanced immunotherapy patient outcomes. Multimodal AI that can accept various data inputs, especially as treatments become more personalized, are prime for helping facilitate advances in...
This webinar on August 15th examined how immune checkpoint inhibitors are being utilized around the globe and in resource limited settings. It provided a forum for physicians from Brazil, Lebanon, and Malawi to discuss their experience in evaluating checkpoint inhibitors as a treatment option as...
Social determinants of health are becoming increasingly understood as having significant impact in immunotherapy patient care. Many of these determinants are captured in the electronic health record (EHR), but very few methods can effectively analyze these data to better determine correlations...
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a commentary detailing what is being described as a Crisis in Clinical Research. The clinical research pipeline is critical to ensuring continued development of novel treatments that can offer patients with...
This webinar on July 10th examined how cell therapies are being utilized around the globe and in resource limited settings. It featured physicians from India, Mexico, and Egypt to discuss their experience in evaluating cell therapies as a treatment option as well as how they overcame challenges...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us